• About Us
  • Overview
  • Strategy
  • Management >
    • Board of Directors
    • Senior Management
  • Scientific Advisory Board
  • Job Opportunities
• Clinical Trials
  • Overview
• Products
  • Advanced Pipeline >
    • TroVax^®
    • ProSavin^®
    • Hi-8 MEL^®
    • MetXia^®
    • RetinoStat^®
  • Early-stage Pipeline >
    • StarGen^®
    • MoNuDin^®
    • SMN-1G
    • Innurex^®
    • ReQuinate^®
    • ImmStat^®
    • EndoAngio-GT
    • Targeted Antibody
• Technology
  • Gene Delivery Technologies
  • Gene Discovery and Target Validation
  • Antibody Delivery
  • Hypoxia Response Element
• Collaborations
  • Corporate Partnerships
  • Technology Licence Agreements
  • Scientific Collaborations and Advisors
• Investors
  • Financing History
  • Accounts
  • Share Price
  • Presentation >
    • Interim Results August 2008
    • Annual General Meeting May 2008
    • Annual Results March 2007
  • Web Casts
  • Announcements
  • Shareholder Meetings
  • Contact
• News
  • Announcements
  • Events
  • Media Coverage
• Contact Us
  • UK >
    • Contacts
    • Directions
    • Map
  • USA >
    • Contacts
    • Directions
    • Map

Date	Article
11 November 2008	Rodman & Renshaw 10th Annual Healthcare Conference
24 September 2008	UBS Global Life Sciences Conference
29 August 2008	Interim Results 2008
11 July 2008	DSMB recommendation for TRIST study
24 June 2008	Jefferies 2nd Annual Healthcare Conference
28 May 2008	FBR Capital Markets Spring Investor Conference
20 May 2008	Rodman & Renshaw Healthcare Conference
18 March 2008	Cowen and Company Annual Health Care Conference
10 March 2008	Annual Results 2007
11 September 2007	Interim Results 2007
31 May 2007	FBR Growth Conference
28 March 2007	TroVax Deal
6 March 2007	Annual Results 2006
5 September 2006	Interim Results 2006
14 March 2006	Annual Results 2005
20 September 2005	Interim Results 2005
21 March 2005	Annual Results 2004
1 September 2004	Interim Results 2004

Website by College Hill - Life Sciences